Blockade of behavioral sensitization by MK-801: Fact or artifact? A review of preclinical data

Psychopharmacology

Volumn 151, Issue 2-3, 2000, Pages 142-151

  Tzschentke, T M ^a   Schmidt, W J ^a  

^a GRÜNENTHAL GMBH   (Germany)

Author keywords

Behavioral plasticity; Conditioning; Dizocilpine; Drug discrimination; Learning; MK 801; NMDA receptor; Sensitization; State dependency

Indexed keywords

4 PHOSPHONOMETHYLPIPECOLIC ACID; AMPHETAMINE DERIVATIVE; BROMOCRIPTINE; COCAINE; DIZOCILPINE; HALOPERIDOL; METHAMPHETAMINE; MORPHINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; BEHAVIOR; CATALEPSY; COMPETITIVE INHIBITION; CONDITIONING; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG DISCRIMINATION; NERVE CELL PLASTICITY; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; REVIEW; SENSITIZATION; STATE DEPENDENT LEARNING;

EID: 0033842306     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130000395     Document Type: Review

References (63)

1. Acquisition, maintenance and reinstatement of intravenous cocaine self-administration under a second-order schedule of reinforcement in rats: Effects of conditioned cues and continuous access to cocaine
2. Dizocilpine (MK-801) blocks tolerance to the analgesic but not to the hyperthermic effect of morphine in the rat
3. Modulation of levodopa-induced motor response complications by NMDA antagonists in Parkinson's disease
4. Issues in the pharmacological modification of cocaine conditioning: Evidence that the stimulus properties of drugs can interact with contextual cues to activate or inactivate cocaine conditioned stimuli
5. MK-801 disrupts the expression but not the development of bromocriptine sensitization: A state-dependency interpretation
6. AMPA antagonist LY293558 blocks the development, without blocking the expression, of behavioral sensitization to morphine
7. Empirical evidence that the state dependence and drug discrimination paradigms can generate different outcomes
8. Multiple within-day conflict testing to define the time course of anxiolytic drug effects
9. Twenty-five years of amantadine therapy in Parkinson's disease
10. Drug-induced reinstatement of heroin- and cocaine-seeking behaviour following long-term extinction is associated with expression of behavioral sensitization
11. Effects of the competitive N-methyl-D-aspartate receptor antagonist, CPP, on the development and expression of conditioned hyperactivity and sensitization induced by cocaine
12. The development of behavioral sensitization to apomorphine is blocked by MK-801
13. Dizocilpine does not prevent the development of tolerance to the anxiolytic effects of diazepam in rats
14. Dizocilpine prevents the development of tolerance to the sedative effects of diazepam in rats
15. The effects of central catecholamine depletions on spatial learning in rats
16. Effects of intra-striatal blockade of glutamatergic transmission on the acquisition of T-maze and radial maze tasks
17. The locomotor activating effects of the D2 agonist bromocriptine show environment-specific sensitization following repeated injections
18. Inhibition of cocaine sensitization by MK-801, a noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist: Evaluation by ambulatory activity in mice
19. NMDA antagonists make learning and recall state-dependent
20. MK-801 prevents the development of behavioral sensitization during repeated morphine administration
21. Failure of the NMDA antagonist MK-801 to antagonize cocaine sensitization of the acoustic startle response in the rat
22. Blockade of 'reverse tolerance' to cocaine and amphetamine by MK-801
23. Reinstatement of alcohol-seeking behavior by drug-associated discriminative stimuli after prolonged extinction in the rat
24. Response-reinforcement learning is dependent on N-methyl-D-aspartate receptor activation in the nucleus accumbens core
25. Previous co-administration of MK-801 blocks the expression of locomotor sensitization to nicotine in rats: State dependency?
26. Glutamate receptor antagonists for neuroleptic malignant syndrome and akinetic hyperthermic parkinsonian crisis
27. Spatial learning deficit after NMDA receptor blockade and state-dependency
28. Can the 'state-dependency' hypothesis explain prevention of amphetamine sensitization in rats by NMDA receptor antagonists?
29. Activation of glutamatergic neurotransmission by ketamine: A novel step in the pathway from NMDA-receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex
30. Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5
31. Spatial discrimination, reversal and active or passive avoidance learning in rats with KA-induced neuronal depletion in dorsal hippocampus
32. Ethanol-induced state-dependent learning is mediated by 5-hydroxytryptamine receptors but not by N-methyl-D-aspartate receptor complex
33. Competitive and noncompetitive NMDA antagonists block sensitization to methamphetamine
34. State-dependent learning and drug discrimination
35. Sensitization and kindling: Implications for the evolution of psychiatric symptomatology
36. Lack of NMDA receptor involvement in caffeine-induced locomotor stimulation and tolerance in rats
37. MK-801 fails to block behavioral sensitization to amphetamine
38. Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis
39. The neural basis of drug craving: An incentive-sensitization theory of addiction
40. Dopamine-glutamate interactions in the basal ganglia
41. Monoamine-glutamate interactions in motor activity and learning
42. State-dependent blockade of haloperidol-induced sensitization of catalepsy by MK-801
43. Cardiac arrest and resuscitation alters the pharmacokinetics of MK-801
44. The effects of fornix and medial prefrontal lesions on delayed non-matching-to-sample by rats
45. Morphine analgesic tolerance: Its situation specificity supports a Pavlovian conditioning model
46. The role of accumbens dopamine in lever pressing and response allocation: Effects of 6-OHDA injected into core and dorsomedial shell
47. Dose-related effects of MK-801 on acute and chronic methylphenidate administration
48. Tolerance and sensitization to the behavioral effects of drugs
49. Development of both conditioning and sensitization of the behavioral activating effects of amphetamine is blocked by the non-competitive NMDA receptor antagonist, MK-801
50. Role of unconditioned and conditioned drug effects in the self-administration of opiates and stimulants
51. Effects of discrete kainic acid-induced hippocampal lesions on spatial and contextual learning and memory m rats
52. Attenuation and reversal of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist, LY274614
53. Evidence for dissociable mechanisms of amphetamine- and stress-induced behavioral sensitization: Effects of MK-801 and haloperidol pretreatment
54. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801
55. Excitatory amino acids and drugs of abuse: A role for N-methyl-D-aspartate receptors in drug tolerance, sensitization and physical dependence
56. Procedural examination of behavioural sensitisation to morphine: Lack of blockade by MK-801, occurrence of sensitised sniffing, and evidence for cross-sensitisation between morphine and MK-801
57. Interactions of MK-801 and GYKI 52466 with morphine and amphetamine in place preference conditioning and behavioural sensitization
58. Does the noncompetitive NMDA receptor antagonist dizocilpine (MK801) really block behavioural sensitization associated with repeated drug administration?
59. Blockade of glutamatergic transmission as treatment for dyskinesias and motor fluctuations in Parkinson's disease
60. Immediate and long-lasting effects of MK-801 on motor activity, spatial navigation in a swimming pool, and EEG in the rat
61. MK-801 (dizocilpine): Synergist and conditioned stimulus in bromocriptine-induced psychomotor sensitization
62. The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants
63. Repeated administration of MK-801 produces sensitization to its own locomotor stimulant effects but blocks sensitization to amphetamine